Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Addressing Cardiovascular Risk Factors Semaglutide has been shown to reduce the risk of major adverse cardiovascular events (MACE) such as heart attack, stroke, or cardiovascular death in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors
Description SEQUENCE: H-His-Ser-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 (trifluoroacetate salt) ONE-LETTER SEQUENCE: HSEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 MOLECULAR FORMULA: C 149 H 226 N 40 O 46 MOLECULAR WEIGHT: 3313.7 STORAGE CONDITIONS: -20 5 C CAS REGISTRY NUMBER: [215777-46-1] SYNONYMS: RESEARCH AREA: Diabetes REFERENCES: U
J Vet Res 72:173182
Making healthy lifestyle changes is the best way to address challenges like menopause and weight gain
